Son Yazılar
- Ginseng'in Cinsiyet ve Yaşa Göre Etkileri
- Kalp Sağlığı icin Düzenli Olarak Tüketilmesi Önerilen Sebze ve Meyveler
- Bebeksi Bir Yüz İçin Doğal Çözümler
- Tok Tutan Besinler
- Enerjik ve Zinde Hissettiren Besinler
- Meme Kanserinden Koruyan 7 Besin
- Yaz Aylarinin Sifali Bitkileri
- Yaban Mersininin Faydaları
- Kirazın Faydaları
- Patates suyunun faydaları
- Soğan Suyunun Faydaları
- Kudret Nari - Faydalari ve Kullanimi
- Cevizin Faydalari
Kudret Narı
Bitki adı:
Balsam apple, fruit
Bilimsel adı:
Momordica charantia
Cins:
Momordica
Familya:
Cucurbitaceae
Diğer adları:
Balsam apple
KUDRET NARI - Momordica cAaranlia L (Cucurbilaceae). San çiçekli, otsu, tırmanıcı ve bir yıllık bir bitkidir. Süs bitkisi olarak yetiştirilir. Meyveleri yara iyi edici olarak kullanılır (24).[Türkçe Bitki Adları Sözlüğü, Turhan Baytop, 2007]
Genel Bilgiler
(La. Fructus Momor.dicae charantiae, Al. Balsamgurken, Fr. Cancombre balsamine, in. Balsam cucumber) Momordica charantia L. (Syıı : M. bal samina Descourt.) (Cucurbitaceae) türünün olgun meyvalarıdır. Bu tür sarı çiçekli, par çalı yapraklı, tırmanıcı ve bir yıllık otsu bir bitkidir (Resim : 53). Vatanı Hindistan ol makla beraber bütün tropikal Asya ve Afri kada bulunur. Türkiyede bahçelerde süs bit kisi olarak yetiştirilmektedir. Dış görünüş : 10 - 15 cm uzunlukta, iğ biçiminde, üzeri pürtüklü, önce yeşil ve son ra parlak sarı veya turuncu · renkli bir mey vadır. Olgunlukta yarılır ve içinden, üstü kır mızı bir arillus ile kaplı tohumlar görülür. Tohumlar 1 cm kadar uzunlukta, böcek bi çiminde, üzerieri desenli ve kenarları kırtık Jıdır. Bileşim : Rezin, müshil etkiye sahip bir bileşik (momordicin) taşrmaktadır. Etki ve kullanılış : Midevi, yumuşatıcı, yara iyi edici ve müshil etkilere sahiptir. Kullaııılış şekli : Olgun meyva, bir şişe içinde, bir miktar zeytin veya badem yağı ile 15 gün kadar güneşte tutulur. Bu müddetin sonunda meyva içinde bulunduğu yağ ile ezi lir. Elde edilen karışım (Kudretnarı yağı) ya ra, çıban veya ekzemalı kısımlar üzerine gün de iki defa sürülür (8). Olgun meyvaların bal ile ezihnesi ile elde edilen macun mide ve barsak ülserlerine karşı dalıilen kullaııılmak tadır. Diğer isimler : Acayip elması, Mucize elması, Papara. ı - Ebert, H.: Ztschr. österr. Apoth.- Ver. 46 : 427 (ı908) . 2 - Tschirch, A.: Handbuch der Pharmakognosie 4 : 2ı4, Leipzig (1935). 3 - Flückiger, F.A.:, Hanbury, D.: Histoire des drogues d'origine vegetale 2 57, Paris (1878). 4 - Leclerc, L.: Traite des simples par ibn El-Beithar ı : 308, Paris (1877) . 5 - Moghadam, S.: Etude historique, botanique et biochimique des mannes de Perse, Paris Eczacılık Fak. doktora tezi, Paris (1930) . 6 - Evliya Çelebi : Seyahatname (Türkçeleştiren : Z. Danışman) 6 : ıo5, istan bul (1970) . 7 - Dymock, W. ve ark.: Phannacographia indi ca ı : 585 (1980). (institute of Health and Tıbbi Research, Pakistan, Karachi, ı972, tıpkı basım). 8 - Baylav, N.: Momordica charantia (kudret nan) mn memleketimizde kullanı lışı hakkında - Ecz. Bült. 4 : ı82 (1962).
Kaynak: Türkiye'de Bitkilerle Tedavi (Turhan Baytop), s. 158
Duke – Ethnobotany
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.6
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 57
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Bliss
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.6
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Gupta
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Lewis
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.6
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Standley,1931
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb30: 140
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.6
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.6
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb30: 140
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb25: 420
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Gupta
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.6
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb24: 361
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb30: 140
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.6
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Bliss
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.6
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb30: 140
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb30: 140
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Gupta
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Brutus
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,19
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb28: 12
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb30: 140
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 61
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Pittier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Lewis
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Bliss
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.6
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.6
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb30: 140
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb28: 12
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.6
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.6
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 62
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.6
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.6
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.6
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb30: 140
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb21: 60
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Ayensu
Kaynak: James A. Duke
Bilimsel Araştırmalar
Breast cancer remains a worldwide public health dilemma and is currently the most common tumour in the globe. Awareness of breast cancer, public attentiveness, and advancement in breast imaging has made a positive impact on recognition and screening of breast cancer. Breast cancer is life-threatening disease in females and the leading cause of mortality among women population. For the previous two decades, studies related to the breast cancer has guided to astonishing advancement in our understanding of the breast cancer, resulting in further proficient treatments. Amongst all the malignant diseases, breast cancer is considered as one of the leading cause of death in post menopausal women accounting for 23% of all cancer deaths. It is a global issue now, but still it is diagnosed in their advanced stages due to the negligence of women regarding the self inspection and clinical examination of the breast. This review addresses anatomy of the breast, risk factors, epidemiology of breast cancer, pathogenesis of breast cancer, stages of breast cancer, diagnostic investigations and treatment including chemotherapy, surgery, targeted therapies, hormone replacement therapy, radiation therapy, complementary therapies, gene therapy and stem-cell therapy etc for breast cancer.
Makaleyi görüntüle
Makaleyi görüntüle
Antioxidants are substances that may protect cells from the damage caused by unstable molecules such as free radicals. Flavonoids are phenolic substances widely found in fruits and vegetables. The previous studies showed that the ingestion of flavonoids reduces the risk of cardiovascular diseases, metabolic disorders, and certain types of cancer. These effects are due to the physiological activity of flavonoids in the reduction of oxidative stress, inhibiting low-density lipoproteins oxidation and platelet aggregation, and acting as vasodilators in blood vessels. Free radicals are constantly generated resulting in extensive damage to tissues leading to various disease conditions such as cancer, Alzheimer's, renal diseases, cardiac abnormalities, etc., Medicinal plants with antioxidant properties play a vital functions in exhibiting beneficial effects and employed as an alternative source of medicine to mitigate the disease associated with oxidative stress. Flavonoids have existed over one billion years and possess wide spectrum of biological activities that might be able to influence processes which are dysregulated in a disease. Quercetin, a plant pigment is a potent antioxidant flavonoid and more specifically a flavonol, found mostly in onions, grapes, berries, cherries, broccoli, and citrus fruits. It is a versatile antioxidant known to possess protective abilities against tissue injury induced by various drug toxicities.
Makaleyi görüntüle
Makaleyi görüntüle
There has been increasing interest in the research on flavonoids from plant sources because of their versatile health benefits reported in various epidemiological studies. Since flavonoids are directly associated with human dietary ingredients and health, there is need to evaluate structure and function relationship. The bioavailability, metabolism, and biological activity of flavonoids depend upon the configuration, total number of hydroxyl groups, and substitution of functional groups about their nuclear structure. Fruits and vegetables are the main dietary sources of flavonoids for humans, along with tea and wine. Most recent researches have focused on the health aspects of flavonoids for humans. Many flavonoids are shown to have antioxidative activity, free radical scavenging capacity, coronary heart disease prevention, hepatoprotective, anti-inflammatory, and anticancer activities, while some flavonoids exhibit potential antiviral activities. In plant systems, flavonoids help in combating oxidative stress and act as growth regulators. For pharmaceutical purposes cost-effective bulk production of different types of flavonoids has been made possible with the help of microbial biotechnology. This review highlights the structural features of flavonoids, their beneficial roles in human health, and significance in plants as well as their microbial production.
Makaleyi görüntüle
Makaleyi görüntüle
In recent years, there has been a great deal of attention toward the field of free radical chemistry. Free radicals reactive oxygen species and reactive nitrogen species are generated by our body by various endogenous systems, exposure to different physiochemical conditions or pathological states. A balance between free radicals and antioxidants is necessary for proper physiological function. If free radicals overwhelm the body's ability to regulate them, a condition known as oxidative stress ensues. Free radicals thus adversely alter lipids, proteins, and DNA and trigger a number of human diseases. Hence application of external source of antioxidants can assist in coping this oxidative stress. Synthetic antioxidants such as butylated hydroxytoluene and butylated hydroxyanisole have recently been reported to be dangerous for human health. Thus, the search for effective, nontoxic natural compounds with antioxidative activity has been intensified in recent years. The present review provides a brief overview on oxidative stress mediated cellular damages and role of dietary antioxidants as functional foods in the management of human diseases.
Makaleyi görüntüle
Makaleyi görüntüle
The use of and search for drugs and dietary supplements derived from plants have accelerated in recent years. Ethnopharmacologists, botanists, microbiologists, and natural-products chemists are combing the Earth for phytochemicals and "leads" which could be developed for treatment of infectious diseases. While 25 to 50% of current pharmaceuticals are derived from plants, none are used as antimicrobials. Traditional healers have long used plants to prevent or cure infectious conditions; Western medicine is trying to duplicate their successes. Plants are rich in a wide variety of secondary metabolites, such as tannins, terpenoids, alkaloids, and flavonoids, which have been found in vitro to have antimicrobial properties. This review attempts to summarize the current status of botanical screening efforts, as well as in vivo studies of their effectiveness and toxicity. The structure and antimicrobial properties of phytochemicals are also addressed. Since many of these compounds are currently available as unregulated botanical preparations and their use by the public is increasing rapidly, clinicians need to consider the consequences of patients self-medicating with these preparations.
Makaleyi görüntüle
Makaleyi görüntüle
